Search

for
Search:

Glossary

Similar Terms

Saccharomyces cerevisiae

Learn

0 / 0 results

— no results

Research

5 / 1000+ results

research Noncontraceptive Benefits of the Estradiol Valerate/Dienogest Combined Oral Contraceptive: A Review of the Literature

16 citations, August 2014 in “International Journal of Women's Health”

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Methotrexate Treatment Patterns in Advanced Therapy-Naïve Patients with Rheumatoid Arthritis: Clinical Characteristics and Outcomes of Patients in the Corrona Registry

research Methotrexate Treatment Patterns in Advanced Therapy-Naïve Patients with Rheumatoid Arthritis: Clinical Characteristics and Outcomes of Patients in the Corrona Registry

June 2019 in “Poster presentations”

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

research FDA Declines Approval of Testosterone Drug for Third Time

2 citations, August 2013 in “The Lancet. Diabetes & endocrinology”

The FDA rejected a testosterone drug again due to safety concerns.

Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?

research Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?

5 citations, August 2018 in “Neurology and Therapy”

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

research Teriflunomide: A Novel Oral Treatment for Relapsing Multiple Sclerosis

16 citations, April 2014 in “Expert Opinion on Pharmacotherapy”

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

View more "bayer healthcare" in research →

Community Join

5 / 40 results

community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

in Research/Science 124 upvotes 1 year ago

The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

community Should I dedicate my university studies to solving hair loss?

in Research/Science 373 upvotes 2 years ago

A 20 year old male who is balding and considering switching to a biology/chemistry program in order to find a low-cost, accessible solution for hair loss. Replies discuss the merits of this idea as well as potential treatments such as Minoxidil, finasteride, RU58841, TM5614, and ADQ.

community When are we getting a cure to hair loss?

in Chat 1 year ago

Potential treatments for hair loss, including Minoxidil, finasteride, RU58841 and various upcoming pharmaceuticals, gene editing and cloning. It is suggested that a cure, if found, would be highly profitable due to the large number of people affected by hair loss globally.

community Bayer says drug research focus no longer on women´s health ( They dismissed HMI-115 because of their focus on women´s health

in Technology 4 upvotes 1 year ago

Hair loss treatments discussed include Minoxidil, Finasteride, and RU58841. Bayer dismissed HMI-115 due to focus shift away from women's health.

community HMI-115: What We Know So Far. HMI-115 (also known as BAY1158061) is a new pharmaceutical drug developed by a biopharmaceutical company called Bioinvent and licensed by Bayer

in Research/Science 51 upvotes 9 months ago

HMI-115 is a new drug developed by Bioinvent and licensed by Bayer, with mixed opinions on its potential effectiveness. Some users are skeptical and prefer proven treatments like Minoxidil, finasteride, and RU58841.

View more "bayer healthcare" in community →